Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) Phase 3 ARCHER II Trial ...

Nearsightedness is the ability to see clearly up close but makes you unable to see far-away objects clearly. However, ...

Researchers investigated the concurrent validity of various visual function measures in differentiating early and ...

Katherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.

Researchers reviewed the course of bacillary layer detachment in treatment naive eyes undergoing aflibercept injections.